$PCOR

Singer Benjamin C sold $197K of PCOR

Singer Benjamin C (Chief Legal Officer; Secretary) sold 3,942 shares of PROCORE TECHNOLOGIES, INC. (PCOR) at $50.00 ($0.20M total) on 2026-05-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Singer Benjamin C
Published Jun 3, 2026, 12:26 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 12:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PCOR
Neutral
medium confidence
Mentioned
$PCOR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PCORNeutralLow
01

Why it matters

The only new datapoint is the disclosed sale amount, share count, execution date (May 29), and confirmation that it was under a pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly check for sentiment impact from insider selling, but 10b5-1 typically dampens interpretability.

03

What to watch

The article lacks context on total insider holdings, whether sales are part of routine scheduled liquidity, and whether other executives/10% holders sold around the same time.

Relevance 6/10Novelty 4/10Timing: Filed June 2; sale executed May 29 (10b5-1)

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct ownership) for Procore Technologies.

Company-level read

Ticker impact

$PCORNeutralMedium confidence
Context

Procore Technologies CFO/Secretary Singer Benjamin C sold 3,942 shares ($197,100) under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term price impact; any reaction would be small and quickly mean-reverting unless accompanied by other news.

Evidence & confidence

The filing provides a concrete transaction size and timing, but 10b5-1 plans are designed to mitigate timing-based informational content.

Market effects

Minimal—single-company insider transaction with no stated operational/regulatory catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or unusually large insider sales can still coincide with bearish expectations; traders may watch for follow-on discretionary selling signals in future filings.

Key entities

  • PROCORE TECHNOLOGIES, INC.

    Subject of the SEC Form 4 insider sale by CFO/Secretary Singer Benjamin C.

  • Singer Benjamin C

    Chief Legal Officer; Secretary who sold 3,942 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PCORMed

Citizens raises Procore stock price target to $77 on customer feedback

Citizens raised its price target for Procore (NYSE:PCOR) to $77 from $71, maintaining a Market Outperform rating. The increase follows customer feedback and due diligence at the company's conference. Procore's stock is down 13% year-to-date but up 8.6% in the past week. Analysts have mixed views, with targets ranging from $55 to $88. Procore's Q3 2026 earnings are due November 3.

$PCORMed

Procore Technologies (PCOR) Gets A Fresh Look On Zacks Upgrade As Undervalued Narrative Holds

Procore Technologies (PCOR) was upgraded to a Zacks Rank #2 rating, highlighting its earnings outlook. The stock has shown mixed performance, with a 24.75% 90-day return but a 13.49% YTD decline. Analysts estimate a fair value of $69.32, suggesting a 12.6% undervaluation. The company's expansion and cross-selling initiatives are noted as growth drivers, but macro headwinds and competition pose risks. PCOR trades at 6.5x sales, a premium to the sector.